The largest database of trusted experimental protocols

12 protocols using ccl2 mcp 1

1

Cytokine Profiling after Didox and IL-33

Check if the same lab product or an alternative is used in the 5 most similar protocols
Following Didox treatment and IL-33 activation for 18 hours, cytokines were measured in the cell culture supernatant via ELISA. Murine ELISA kits were purchased from Biolegend for IL-6, TNF, and MCP-1 (CCL2) and Peprotech (Rocky Hill, NJ) for IL-13 and MIP-1α (CCL3). Assays were performed in duplicate according the manufacturers’ protocols.
+ Open protocol
+ Expand
2

Cell Competition Assay with Signaling Modulators

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following reagents and recombinant proteins were used for cell competition assay: sodium dichloroacetate (Sigma-Aldrich, #347795); recombinant human IL-6 (PEPRO TECH, #200-06), IL-8 (PEPRO TECH, #200-08M), GDF-15/IMC-1 (PEPRO TECH, #120-28C), MCP-1 (CCL2, PEPRO TECH, #300-04), HGF (PEPRO TECH, #100-39), TGF-β1 (PEPRO TECH, #100-21), CD105 protein (Abcam, #ab54338), BSG protein (P01, Abnova, #H00000682-P01), DPP4 protein (P01, Abnova, #H00001803-P01), pentraxin 3/TSG-14 (R&D Systems, #1826-TS), and uPAR protein (84–95) (scrambled peptide, Anygen, #C180084).
+ Open protocol
+ Expand
3

Cytokine-Mediated Podocyte Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary human GECs, primary podocytes subcultured from human donor kidney, and organoid-derived podocytes were treated with 50 ng/mL, 20 ng/mL, or 10 ng/mL concentration of the following cytokines: recombinant human CXCL9 (BioLegend, 578102); recombinant human CXCL10 (BioLegend, 573502); recombinant human CXCL13 (BioLegend, 573502); IL-1β (PeproTech, 200-01B); IL-15 (PeproTech, 200-15); IL-18 (BioLegend, 592102); IL-8 (BioLegend, 574202); IFN-α1 (MilliporeSigma, SRP4596); IFN-β (PeproTech, 300-02BC); IFN-γ (MilliporeSigma, I17001); IL-6 (PeproTech, 200-06); TNF-α (PeproTech, 300-01A); MCP-1 (CCL2; PeproTech, 300-04); MIP-1α (CCL3; PeproTech, 300-08); IL-10 (PeproTech, 200-10); IL-7 (PeproTech, 200-07); IL-2 (PeproTech, 200-02); and G-CSF (PeproTech, 300-23). A standardized cytokine concentration of 50 ng/mL was predetermined on the basis of precedent from human cell treatments evaluating cytokine-shock syndromes in COVID-19 infection (17 (link)). Follow-up experiments used concentrations of 20 ng/mL and 10 ng/mL. Subsequent treatments, including organoid and organoid-derived podocyte experiments, were performed using a cytokine concentration of 10 ng/mL. The JAK1/2 inhibitor baricitinib (INCB028050; Selleckchem, S2851) was used at 10 μM final concentration in all experiments.
+ Open protocol
+ Expand
4

Quantitative Real-Time PCR for Kidney Injury Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Reverse transcription was performed on equal amounts of total RNA by using random hexanucleotide primers to produce a cDNA library for each sample. Real-time PCR reactions were run on an iCycler iQ Real-Time PCR Detection System using Taqman Universal PCR Master Mix (Applied Biosystems, P/N 4304437). KIM-1, osteopontin (OPN)/secreted phosphoprotein-1, fibronectin-1, monocyte chemotactic protein-1 (MCP-1/CCL2), and β-actin gene-specific Taqman probe and primer sets were obtained from Applied Biosystems as Assays-on-Demand (AOD) gene expression products. The AOD identification numbers were Rn00597703_m1 for KIM-1, Rn00563571_m1 for OPN, Rn00569575_m1 for fibronectin-1, Rn00580555_m1 for MCP-1, and 4331182 for the rat β-actin endogenous control. Each sample was run in triplicate, and the comparative threshold cycle (Ct) method was used to quantify fold increase (2–∆∆Ct) compared with controls.
+ Open protocol
+ Expand
5

Quantifying MCP-1 Expression in LPS-Stimulated THP-1 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
From the LPS-stimulated THP-1cells, total RNA was isolated using TRIzol™ reagent (Invitrogen, Carlsbad, CA, USA), and 1 µg of total RNA was used to generate complementary DNA (cDNA) using AffinityScript Multiple Temperature cDNA Synthesis Kit (Agilent Technologies, Inc., Santa Clara, CA, USA). Real time semi-quantitative polymerase chain reaction (PCR) was carried out using TaqMan® Fast Universal PCR Master Mix (2×) (Applied Biosystems, Foster City, CA, USA) and ViiA7 Real-Time PCR Detection System (Applied Biosystems). Human TaqMan probes and primers were purchased from Applied Biosystems: MCP-1/CCL2 (assay ID: Hs00234140_m) [18 (link)].
+ Open protocol
+ Expand
6

Inflammatory Mediator Procurement Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lipopolysaccharide (O111:B4; LPS) was purchased from Sigma‐Aldrich (Schnelldorf, Germany). Recombinant murine IL‐6, CCL2 (MCP‐1) and LIF were from PeproTech (London, UK). Prostaglandin E2 and celecoxib were purchased from R&D Systems (Abingdon, UK).
+ Open protocol
+ Expand
7

Quantification of Plasma Cytokine and Chemokine Levels

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma cytokine and chemokine levels of the following six molecules were measured using ELISA kits, in accordance with the manufacturer’s instructions: interferon gamma (IFN-γ) (cat. 900-K27, Peprotech, New Jersey, NJ, USA); tumor necrosis factor alpha (TNF-α) (cat. 900-K25, Peprotech); C-C motif chemokine ligand 2 (CCL2/ MCP-1) (cat. 900-K31, Peprotech); C-X-C motif chemokine ligand 10/ interferon protein-10 (CXCL10/IP-10) (cat. 900-K39, Peprotech); interleukin-6 (IL-6) (cat. DY206, R&D Systems, Minneapolis, MN, USA); and IL-10 (cat. DY217B, R&D Systems). Standard curves of known concentrations of recombinant human cytokines or chemokines were used to convert optical density (OD) into concentration units (pg/mL). The plates were read in a SpectraMax Paradigm® machine (Molecular Devices, CA, USA).
+ Open protocol
+ Expand
8

Carvedilol's effect on T. cruzi infection

Check if the same lab product or an alternative is used in the 5 most similar protocols
To analyze the interference of carvedilol therapy on inflammatory response associated with T. cruzi experimental infection, immunoassays were performed for inflammatory cytokine and chemokine TNF and CCL2/MCP-1 (PeproTech, NJ, USA), respectively, and for the regulatory cytokine IL-10 (PeproTech, NJ, USA). Blood from the orbital venous sinus (0.5 mL) was collected during euthanasia and centrifuged (1500 g for 15 minutes at 4°C). The plasma was stored at −80°C. Next, these samples were used to measure TNF, CCL2, and IL-10, according to the protocol recommended by the manufacturer. The samples were simultaneously measured in triplicate.
+ Open protocol
+ Expand
9

Standardized T-cell Migration Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Migration T-cell assays were performed based on previous standardization assays and conditions reported for T-cell migration (17 (link)). Chemoattractants CCL2 (MCP-1) (200 ng/ml) and CCL19 (200 ng/ml) (PeproTech Cranbury, NJ; USA) in 150 μl of RPMI media were added alone or together to the bottom well of a 96-well chemotaxis plate (Cytoselect 96-well cell migration assay-fluorometric format, Cell Biolabs, Inc. San Diego, CA, USA.). T cells cultured 24 h with supernatants were recovered and suspended in RPMI 1640 serum-free media (4 × 106 cells/ml), and 100 μl of suspension cells were added on top of the membrane (5 μm pore size). Cells were allowed to migrate for 3 h at 37°C in 5% CO2. Cells in the membrane were recovered using 150 μl of cell detachment solution and lysed. The total number of transmigrated cells was quantified using CyQuant® GR Dye (Synergy™ HT, BioTek, Inc., USA). Cells in RPMI 1640 with BSA 1% were used as blanks for each chemokine.
+ Open protocol
+ Expand
10

Quantifying Plasma Cytokine Profiles

Check if the same lab product or an alternative is used in the 5 most similar protocols
The concentrations of 9 parameters, including cytokines and chemokines present in the plasma samples, were estimated using ELISA kits, in accordance with the manufacturer’s instructions. The cytokines/chemokines that were assayed included IFN-γ (cat. 900-K27, Peprotech, NJ, USA); TNF-α (cat. 900-K25, Peprotech, NJ, USA); CCL2/ MCP-1 (cat. 900-K31, Peprotech, NJ, USA); CXCL10/IP-10 (cat. 900-K39, Peprotech, NJ, USA); IL-6 (cat. DY206, R&D Systems, MN, USA); IL-10 (cat. DY217B, R&D Systems, MN, USA); CCL5/RANTES (cat. 900-K33, Peprotech, NJ, USA); CCL4/ MIP1-β (cat. 900-T36, Peprotech, NJ, USA); and CXCL-8/ IL-8/ (DY208, R&D Systems, MN, USA). Standard curves of known concentrations of recombinant human cytokines or chemokines were used to convert optical density (OD) into concentration units (pg/mL). The levels of cytokines/chemokines were analyzed using a SpectraMax Paradigm® instrument (Molecular Devices, San Jose, CA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!